 |
| Contact us |
 |
| AUSTRALIA |
sanofi-aventis
Talavera Corporate Centre
Building D
12-24 Talavera Road
Macquarie Park, NSW 2113
+61 (0)2 8666 2000
|
 |
| NEW ZEALAND |
sanofi-aventis
James & Wells Tower
Part Level 8, 56 Cawley St
Ellerslie, Auckland
+64 (0)9 580 1810
|
| Contact us |
 |
|
 |
|
|
 |
| Sanofi-aventis Worldwide |
 |
We put patients at the heart of our activities with the aim of improving their lives, today and tomorrow.As a global diversified healthcare company, sanofi-aventis has a wide range of prevention and treatment solutions to fit the individual needs of patients. Listening to our patients must inform all our decisions and actions: we must understand patient needs and what healthcare providers and payers require, then define what we can bring to them. Not only are we looking for more effective and safer solutions to improve human health, but also for more affordable and cost-effective therapies to which all patients will have access. We develop an innovative approach to provide sustainable access to medicines to people in emerging countries. One way of translating our commitment into reality is by forging partnerships with patient associations. This helps us better understand the needs and expectations of patients through dialog and exchange of know-how. We partner with patient associations to help address the broader issues along the patient journey, such as prevention, awareness and living and coping better with medical conditions. Sanofi-aventis recognizes the crucial importance of patient-centered healthcare and ensuring that patient needs are placed at the center of healthcare policy discussions, irrespective of therapeutic area or specific geography. Sanofi-aventis also recognises its corporate social responsibilities through a range of philanthropic and community initiatives. See Our Social Responsibility.
|
2008 Key FiguresSanofi-aventis consolidated sales for 2008 were €27,568 million: - €24,707 million in pharmaceuticals, a rise of 3.1%
- €2,861 million in human vaccines, up 9.6%
2008 adjusted net income was €7,068 million. 2008 Research and Development spending was €4.6 billion.
|
| Sanofi-aventis in Australia & New Zealand |
 |
In Australia & New Zealand Sanofi-aventis is one of the leading healthcare companies in Australia. With three distinct divisions focusing on Pharmaceuticals, Consumer Healthcare and Vaccines, sanofi-aventis Australia/New Zealand is a horizontally integrated healthcare provider with products ranging from complementary medicines, through to patented medicines, generics, over the counter medicines and vaccines. We are committed to improving the health and well-being of Australians and New Zealanders through our diverse and extensive range of products that span the complete spectrum of wellness, treatment and prevention.
|
Health and wellness Our Consumer Healthcare division manufactures, markets and distributes a wide range of leading healthcare-related consumer products and over the counter brands. Our broad range of nutraceuticals (vitamins and supplements) are relied upon by those in the community who value their natural health and seek to keep their health better by taking a balanced, positive and proactive approach to their health and wellbeing. Our large range of well recognised and respected pharmacy over the counter brands in areas such as pain management and allergy ensures sanofi-aventis has a prominent place at pharmacy level. Prevention Our role in disease prevention is the focus of sanofi pasteur, the fully integrated vaccines division of sanofi-aventis. Sanofi Pasteur, is the world leader in the vaccines industry, offering the broadest range of vaccines in five critical areas: influenza, peadiatric combinations and poliomyelitis vaccines, adult and adolescent booster vaccines and meningitis as well as a range of travel vaccines and measles, mumps and rubella (MMR) vaccines. Sanofi Pasteur is also developing H1N1 (swine flu) pandemic vaccines for supply. Treatment Our prescription medicines division provides much needed treatment options for a vast range of chronic health conditions ranging from osteoporosis, diabetes, cardiovascular disease, conditions of the central nervous system, thrombosis and oncology. Combining the pharmacy ‘back of store’ presence of sanofi-aventis’ prescription medicines with the ‘front of store’ presence of sanofi-aventis Consumer Healthcare products confirms the power of the sanofi-aventis ‘Total Store Concept’. Sanofi-aventis ANZ Sanofi-aventis Australia and New Zealand employs almost 1,000 staff with head offices for prescription pharmaceuticals and vaccines located in Sydney, NSW and Consumer Healthcare in Brisbane, Queensland. Additional State sales offices are located in Adelaide, Perth and Melbourne. The New Zealand headquarters is located in Auckland. To find out more about our three core divisions, click on the links below:
|
| Updated: December 18, 2009 |
|
|
 |
 |
Corporate Information
Get more information about sanofi-aventis group
|
 |
|
 |
 |
 |
| July 29, 2010 |
 |
 |
Second Quarter 2010 Global Results |
 |
 |
|
 |
 |
 |
 |
|
 |
|